Searched for
CHEAPER DRUGS
'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Fable 5: Anthropic's latest AI model could transform IT, but at a costAnthropic's Fable 5 AI model showcases advanced agentic coding, capable of autonomous complex task completion and outperforming benchmarks....
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
- IT a tactical buy; Devarsh Vakil reveals 5 sectors worth buying as markets turn volatileLeading analyst Devarsh Vakil suggests Indian markets offer compelling buying opportunities now, with valuations correcting to attractive l...
- CEOs are getting ruthless about worker performanceCorporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...
- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...
- Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarityEli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...
- Quote of the day by Rudyard Kipling: “He travels the fastest who travels alone” — inspiring lessons on independence, self-confidence and staying focused on goals by The Jungle Book authorRudyard Kipling’s famous quote about travelling alone gives an important lesson about confidence, focus, and self-belief. The writer of The...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Forget Silicon Valley - a viral video just exposed the San Francisco nobody talks about, and it's shocking millionsSan Francisco viral video: A viral video from San Francisco's Tenderloin neighborhood depicts a stark reality of widespread drug use, shock...
- Is your paneer real? Maharashtra orders restaurants to disclose types of cottage cheese used in billMaharashtra's Food and Drug Administration now mandates restaurants and eateries to clearly disclose if "paneer" is genuine or a substitute...
- Obesity drug market to gain as Indians pop the pill and Chinese bring moreIndia's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...
- Traditional knowledge, cheaper drugs on India's agenda for WTOIndia has also sought amendment of laws on unilateral action by members on trade issues.
- EU court upholds EUR 13.96 mn fine on Unichem Lab in Perindopril litigationIn 2014, six global drug makers were fined EUR 427.7 million for striking deals to prevent entry of cheaper version of blood pressure drug ...
Load More
